Old Web
English
Sign In
Acemap
>
authorDetail
>
Minako Funakubo
Minako Funakubo
Novartis
Medicine
Asthma
Melanoma
In vivo
Matrix metalloproteinase
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-Effectiveness Analysis of Omalizumab for Severe Allergic Asthma in Japan Using Real-World Evidence.
2022
Value in health regional issues
Ataru Igarashi
Harneet Kaur
Abhay Choubey
Akshay Popli
Madhusubramanian Muthukumar
Hajime Yoshisue
Minako Funakubo
Ken Ohta
Show All
Source
Cite
Save
Citations (0)
In-hospital resource utilization, worsening heart failure, and factors associated with length of hospital stay in patients with hospitalized heart failure: A Japanese database cohort study
2020
Journal of Cardiology
Hironobu Mitani
Minako Funakubo
Naoki Sato
Hiroki Murayama
Roberto Abi Rached
Nobutomo Matsui
Shigeto Yoshida
Takanori Ishii
Naotsugu Oyama
Show All
Source
Cite
Save
Citations (1)
A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan
2019
npj Primary Care Respiratory Medicine
Hiromasa Inoue
Masanari Kozawa
Ki Lee Milligan
Minako Funakubo
Ataru Igarashi
Emil Loefroth
Show All
Source
Cite
Save
Citations (13)
Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
2008
Journal of Dermatology
Yuichiro Yoshino
Toshiro Kageshita
Motowo Nakajima
Minako Funakubo
Hironobu Ihn
Show All
Source
Cite
Save
Citations (20)
1